Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNationwide Ccds Regulatory News (NBS)

Share Price Information for Nationwide Ccds (NBS)

Share Price is delayed by 15 minutes
Get Live Data
129.00    0.00 (0.00%)
Bid:
127.00
Ask:
131.00
Spread: 4.00 (3.15%)
Market Cap: £1.18b
NBS Live PriceLast checked at - London Stock Exchange

Intraday Nationwide Ccds Share Chart

Part VII Transfer

26 Feb 2026 11:00

RNS Number : 4292U
Clydesdale Bank PLC
26 February 2026
 

CLYDESDALE BANK PLC

LEI: NHXOBHMY8K53VRC7MZ54

Transfer of banking business under Part VII of the Financial Services and Markets Act 2000

Clydesdale Bank PLC (trading as Virgin Money) ("CB") announces that on 23 February 2026, the High Court of Justice approved the application for an Order under section 111(1) of the Financial Services and Markets Act 2000 (as amended) sanctioning a banking business transfer scheme (the "Scheme") providing for the transfer to Nationwide Building Society ("NBS") of the Transferring Business (as defined in the document setting out the terms of the Scheme (the "Scheme Document")). The Transferring Business consists of the entire business of CB (with the exception of a small number of products, contracts and arrangements, which constitute the Excluded Business (as defined in the Scheme Document)).

The Scheme will take effect on 2 April 2026 at 23.59.

The legal transfer is a major milestone in the integration of Nationwide and Virgin Money. It is the next step in creating a mutually owned, full-service organisation that works solely for the benefit of members and customers. We expect commencement of customer rebranding and systems migrations in 2026 and plan to materially complete migration activity in the subsequent 2-3 years as we continue our customer-first approach to integration.

A copy of the Scheme Document and other documents relating to the Scheme are available on CB's website at www.virginmoney.com/nationwide-transfer.

 

26 February 2026

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBRGDDSDDDGLU
Date   Source Headline
17th Feb 20165:10 pmRNSPublication of Final Terms
12th Feb 20162:54 pmRNSPublication of Supplement - Replacement
12th Feb 20162:42 pmRNSPublication of Supplement
12th Feb 20167:00 amRNSInterim Management Statement
2nd Feb 201610:00 amRNSJOE GARNER TO JOIN AS CEO ON 5 APRIL 2016
28th Jan 20165:33 pmRNSPublication of Final Terms
28th Jan 20165:25 pmRNSPublication of Final Terms
27th Jan 201612:59 pmRNSPublication of Final Terms
20th Jan 201611:25 amRNSPublication of Final Terms
18th Jan 20163:18 pmRNSPublication of Final Terms
18th Jan 201612:06 pmRNSPublication of Final Terms

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.